The proinflammatory cytokine tumor necrosis factor-α(TNF-α) occurs in CNS tissue in neurological disorders, infection, and injury. Its excessive production is believed to contribute to local pathology, in which case modulation of TNF-αproduction should promote survival of neural tissue. The neuropeptideα-melanocyte stimulating hormone [α-MSH (1-13)] inhibits TNF-αproduction in vivo and in vitro, and in this research we tested the capacity of the peptide, and of an anti-inflammatory COOH-terminal tripeptide fragment of it, to inhibit TNF-αproduction induced by bacterial endotoxin in cells of a human glioma line (A-172, anaplastic astrocytoma cells). Both peptides were effective, although theα-MSH (1–13) sequence was more potent. Preincubation of the cells withα-MSH (1–13) markedly increased its effectiveness. The anticytokine effect ofα-MSH in glioma cells may be mediated by human melanocortin-1 receptors; mRNA for this receptor subtype was isolated from resting A-l 72 cells. These results, combined with prior evidence of effectiveness ofα-MSH molecules in modulating inflammatory processes and of their low toxicity, suggest that the molecules may be useful in the treatment of CNS disorders that have an inflammatory component.
- CNS disorders
- Neurological disorders
- Tumor necrosis factor-α
- α-Melanocyte-stimulating hormone
ASJC Scopus subject areas
- Endocrine and Autonomic Systems